New drug discovery targets relevant to neurodegenerative diseases

Información del proyecto

DRUGS IN NEURODEGENE

Identificador del acuerdo de subvención: QLK6-CT-1999-50409

Proyecto cerrado

Fecha de inicio 17 Abril 2001

Fecha de finalización 16 Abril 2005

Financiado con arreglo a

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Coste total € 202 224,00

Aportación de la UE € 202 224,00

Coordinado por

SCHERING-PLOUGH SPA
Italy

Objetivo

The aim of the project is to study neuroprotection in experimental models of human diseases. In particular we will study the effects of capsize inhibitors and that of cannabinoid receptor activity.

Ámbito científico

• medical and health sciences › basic medicine › pharmacology and pharmacy › drug discovery

Programa(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Tema(s)

• 1.1.1.-6. - Key action The Ageing Population and Disabilities

Convocatoria de propuestas

Data not available

Régimen de financiación

BUR - Bursaries, grants, fellowships

Coordinador

SCHERING-PLOUGH SPA

• Aportación de la UE: Sin datos
• Dirección: via Olgettina 58 ; 20132 MILANO ; Italia
• Coste total: Sin datos